bioRxivCancer Biology
Co-regulation and functional cooperativity of FOXM1 and RHNO1 bidirectional genes in ovarian cancer
C. J. Barger, C. Branick, L. Chee, M. Albahrani, D. Klinkebiel, R. Drapkin, K. Odunsi, L. Zou, A. Karpf
Abstract
We report that the oncogenic transcription factor FOXM1 is arranged in a head-to-head configuration with RHNO1, a gene involved in the ATR/CHK1-dependent DNA replication stress (DRS) response. FOXM1 and RHNO1 are both amplified and upregulated in high-grade serous ovarian cancer (HGSC). FOXM1 and RHNO1 expression are closely associated in normal and cancer tissues, including single cells, and a bidirectional promoter (F/R-BDP) mediates balanced expression. Targeting of FOXM1 and RHNO1 in HGSC cells using shRNA, CRISPR mutagenesis, or CRISPR interference directed to the F/R-BDP reduced DNA homologous recombination repair (HR) capacity, increased DNA damage, reduced clonogenic survival, and sensitized HGSC cells to the poly-ADP ribosylase inhibitor (PARPi) olaparib. Thus, there is functional cooperativity between FOXM1 and RHNO1 in cancer cells, and combinatorial targeting of this bidirectional gene pair may be a novel cancer therapeutic strategy. More broadly, our data provide evidence that bidirectional gene units function in human cancer.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MiR-4521 perturbs FOXM1-mediated DNA damage response in breast cancer
R. Kuthethur, D. Adiga, … S. Chakrabarty·bioRxiv·Feb 8, 2023
- Inhibition of RNA Polymerase I Transcription Activates Targeted DNA Damage Response and Enhances the Efficacy of PARP Inhibitors in High-Grade Serous Ovarian Cancer
E. Sanij, K. M. Hannan, … R. B. Pearson·bioRxiv·Apr 29, 2019
- Targeting RNA Polymerase I transcription synergises with TOP1 inhibition in potentiating the DNA damage response in high-grade serous ovarian cancer
S. Yan, P. B. Madhamshettiwar, … K. T. Chan·bioRxiv·Nov 20, 2019
- MYC and HSF1 Cooperate to Drive PLK1 inhibitor Sensitivity in High Grade Serous Ovarian Cancer
Imade Imasuen, Matthew O’Malley, … Richard L. Carpenter·Cancer Research CommunicationsPeer-reviewed·Jan 20, 2025
- Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance.
H. A. Segeren, K. Wierenga, … B. Westendorp·bioRxiv·Mar 26, 2024
- The DEAD-box protein p68 and B-catenin: the crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer
S. TABASSUM, M. BASU, M. Ghosh·bioRxiv·Oct 28, 2022